All Reports Events Blogs Videos
Showing 51 results
  • Thematic Report
    May 04, 2026

    The global Clinical Research Organization (CRO) market is undergoing a transformation, shaped by rising clinical trial complexity, increasing regulatory requirements, and growing demand for faster, more efficient drug development. CROs continue to play a pivotal role…
  • Viewpoint
    April 28, 2026

    The global safety database market is at an inflection point, driven by increasing complexities in Pharmacovigilance (PV) operations, growing regulatory expectations, and rapid expansion of data sources such as real-world evidence, digital health tools, and patient-generated…
  • Market Insights™
    Nov. 05, 2025

  • Blog
    Nov. 02, 2025

    The clinical outsourcing market is undergoing a transition with the emergence of specialist-focused Clinical Research Organizations (CROs). A specialist CRO concentrates its expertise in a defined area, such as a therapeutic focus, trial phase or technology, or geographic niche, rather than offering broad,…
  • Provider Compendium
    Oct. 27, 2025

    The Loyalty Platform – Provider Compendium 2025 provides detailed and fact-based snapshots of 12 loyalty platform providers. Each profile offers a structured overview of the provider’s product and capability focus areas, including platform suite and deployment…
  • Provider Compendium
    Oct. 24, 2025

    The Property and Casualty (P&C) insurance industry is rapidly transforming, driven by volatile market conditions, cost pressures, and increasing operational complexities. As insurers strive for profitable growth and agility, they are reconfiguring core operations and sourcing…
  • State of the Market
    Oct. 01, 2025

    The surge in case volumes, more stringent regulatory demands, and therapeutic areas’ rising complexities are significantly transforming pharmacovigilance (PV). As the industry adapts to more tailored reporting requirements and longer patient monitoring periods, enterprises are under…
  • Provider Compendium
    Sep. 30, 2025

    In recent years, life sciences enterprises have reoriented their R&D investments, prioritizing pipeline efficiency and a strategic focus on large and novel molecules. This shift has intensified efforts around cost containment and created a stronger need…
  • Provider Compendium
    Sep. 16, 2025

    Pharmacovigilance (PV) operations have become a strategic priority for life sciences enterprises facing heightened regulatory scrutiny, evolving safety standards, and growing complexity across global markets. This report provides an in-depth assessment of 12 leading PV service…
  • Webinar Deck
    July 31, 2025

    Life sciences commercial teams are facing tighter budgets, faster launch cycles, and growing pressure to prove ROI from every investment and engagement. In this high-stakes environment, a new breed of specialist providers is stepping up, reshaping…
  • Event
    July 29, 2025

    Life sciences commercial teams are facing tighter budgets, faster launch cycles, and growing pressure to prove ROI from every investment and engagement. In this high-stakes environment, a new breed of specialist providers is stepping up, reshaping…
  • PEAK Matrix®
    July 16, 2025

    In recent years, life sciences enterprises have reprioritized and overhauled their R&D investments. They now focus on streamlining their pipelines and shifting toward new and large molecules. This transformation has compelled aggressive cost containment initiatives, prompting…
  • Viewpoint
    June 12, 2025

    Life sciences enterprises are increasingly turning to Real-world Evidence (RWE) as an essential input for decision-making across the product life cycle – from early-stage R&D to post-market access and safety. RWE offers validated insights into treatment…
  • Blog
    May 23, 2025

    On May 12, 2025, President Donald Trump signed a high-impact executive order titled “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients.” The order directed the U.S. Department of Health and Human Services (HHS) to implement a…
  • PEAK Matrix®
    April 03, 2025

    Pharmacovigilance (PV) has evolved into a strategic imperative, driven by intensified regulatory scrutiny and an increasing focus on patient safety. Pharmaceutical companies now face a rapidly evolving landscape characterized by rising adverse event volumes, fragmented real-world…
  • Provider Compendium
    Feb. 20, 2025

    Enterprises are increasingly recognizing their data ecosystem gaps as they strive to fully harness generative AI’s potential. Consequently, they are prioritizing AI-ready data ecosystems, emphasizing robust data management and governance. When scaling their AI initiatives, they…
  • Provider Compendium
    Dec. 12, 2024

    The Procurement Outsourcing (PO) Services – Provider Compendium 2024 offers comprehensive, fact-based profiles of leading PO service providers. The report highlights their service offerings, scale of operations, technology solutions, delivery locations, and recent developments. This report…
  • Viewpoint
    May 02, 2024

    The healthcare industry is transforming rapidly, driven by rising costs, stricter regulations, and a growing emphasis on member experience. This pressure highlights the need for healthcare payers to improve efficiency and effectiveness, especially in light of…
  • Provider Compendium
    Jan. 31, 2024

    The growing cost of healthcare services and a gap in the quality of care provided in traditional fee-for-service models have propelled the traction of value-based care models in the market. With this in mind, the Centers…
  • Market Insights™
    Aug. 23, 2023

Items per page